It is uncertain, given the lack of recent data and the inconclusive nature of previous data, whether ethambutol is cleared by hemodialysis using contemporary dialyzers. We measured serum ethambutol concentrations before, during, and 1 h after hemodialysis in a 75-year-old Caucasian man receiving ethambutol for disseminated Bacille Calmette-Guérin infection. There was a mean 41% decrease in serum ethambutol concentration during dialysis, confirming the hemodialyzability of ethambutol and the utility of drug monitoring in ensuring safety.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444158 | PMC |
| http://dx.doi.org/10.1128/AAC.01988-16 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A Lumbar Drug-Resistant Tuberculosis: A Case Report and Review of Literature.
Infect Drug Resist
December 2024
Department of Spine Surgery and Orthopaedics, Xiangya Hospital, Central South University, Changsha, 410008, People's Republic of China.
Introduction: Tuberculosis is prevalent in high-burden countries. However, spinal multi-drug resistant tuberculosis (MDR-TB) in patients with normal immune function is a disease that is prone to misdiagnosis and even delayed diagnosis. Recently, we successfully treated one such patient.
View Article and Find Full Text PDFAtypical Mycobacterium Skin Infection in a Heart Transplant Patient.
Cureus
November 2024
Cardiology, Tampa General Hospital, Tampa, USA.
Atypical mycobacterium infections are an uncommon cause of cutaneous infection, and they are especially rare infections of the facial region. Immunocompromised patients, such as transplant patients, are at higher risk for infections of this nature with concurrent hematogenous spread to other organ systems. We report a patient with a previous heart transplant who developed an atypical mycobacterium infection of the skin with possible dissemination to the lung.
View Article and Find Full Text PDFIn vivo imaging identified efficient antimicrobial treatment against Mycobacterium marinum infection in mouse footpads.
Sci Rep
October 2024
Department of Mycobacteriology, Leprosy Research Center, National Institute of Infectious Diseases, Aoba-cho, Higashimurayama, Tokyo, Japan.
Article Synopsis
- Mycobacterium marinum is a leading cause of non-tuberculous mycobacterial infections, notably fish tank granuloma, and is more resistant to treatments compared to other NTM bacteria.
- Current treatment protocols for M. marinum are not well-established, and few studies have investigated how effective existing antibiotics are in living mammals.
- The study introduced a noninvasive imaging method to track M. marinum infections in mice, revealing that a combination of specific antibiotics helped clear the infection, while also highlighting the role of immune responses in granuloma development similar to tuberculosis.
[Miliary Pulmonary Tuberculosis After Intravesical BCG Instillation in a Patient with High-Grade Bladder Cancer].
Mikrobiyol Bul
October 2023
Hisar Intercontinental Hospital, Department of Urology, İstanbul, Türkiye.
Intravesical administration of Bacillus Calmette-Guerin (BCG) vaccine is used in the treatment of superficial bladder cancer. In clinical practice, intravesical BCG immunotherapy after transurethral tumor resection is a highly effective treatment option in preventing tumor recurrence and progression in medium and high risk superficial bladder tumors. Since patients are given live tuberculosis (TB) bacillus, serious side effects such as pneumonia, sepsis and even death can be seen.
View Article and Find Full Text PDFNanotherapeutic delivery of antibiotic cocktail enhances intra-macrophage killing of .
Front Antibiot
July 2023
Department of Veterinary Microbiology and Preventive Medicine, Iowa State University, Ames, IA, United States.
is a waterborne pathogen responsible for tuberculosis-like infections in cold-blooded animals and is an opportunistic pathogen in humans. is the closest genetic relative of the complex and is a reliable surrogate for drug susceptibility testing. We synthesized and evaluated two nanoparticle (NP) formulations for compatibility with rifampicin, isoniazid, pyrazinamide, and ethambutol (PIRE), the front-line antimycobacterial drugs used in combination against active tuberculosis infections.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!